Urothelial Cancer - FOI Response Register

1. How many patients were treated for Urothelial cancer (any stage) in the past 3 months with the following treatments:

Atezolizumab (Tecentriq)

Avelumab (Bavencio)

Carboplatin single agent or in any other combination

Carboplatin with Gemcitabine

Carboplatin with Paclitaxel

Cisplatin single agent or in any other combination

Cisplatin with Gemcitabine

Cisplatin with Gemcitabine + Nivolumab (Opdivo)

Enfortumab Vedotin + Pembrolizumab (Padcev + Keytruda)

Nivolumab (Opdivo)

Pembrolizumab (Keytruda)

Other active systemic anti-cancer therapy -1

Palliative care only

2. Does your trust participate in any ongoing clinical trials for the treatment of urothelial cancer? If so, can you please provide the name of each trial along with the number of patients taking part?

No. Clinical Trials are conducted by NHS Grampian